An observational clinical study of the influence of phacoemulsification on choroidal neovascular membrane activity in age related macular degeneration.

Phacoemulsification has no clinically significant impact on the activity of pre-existent CNV secondary to AMD. Phacoemulsification should be offered to patients with AMD and cataract that limits vision, regardless of CNV activity.